Ignacio
Gil Bazo
Chercheur jusqu' 2022
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublications en collaboration avec des chercheurs de David Geffen School of Medicine at UCLA (1)
2019
-
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 20, Núm. 12, pp. 1655-1669